Generalised periodontitis in a smoker with poorly controlled type 2 diabetes
A 46-year-old woman attends for the first time complaining that her gums bleed and her upper front teeth are drifting. She has type 2 diabetes treated with metformin; her last HbA1c was 8.8%, and her GP has recently added a second agent. She smokes 20 cigarettes a day and has done for 25 years. Examination shows generalised bleeding on probing, plaque and calculus, probing depths of 5-7 mm in all sextants with generalised horizontal bone loss of about 40%, and recession with 2 mm mobility on 21 and 11. Tooth 46 has a grade II furcation involvement, an 8 mm pocket and grade III mobility, and is symptomless. She works shift work, has two young children, and says she can manage no more than one appointment every six months.
1. How would you classify her periodontal condition, and what in the history drives that classification?
Read the worked answer
Generalised periodontitis, Stage III, Grade C.
Reasoning from the data rather than from labels:
- Stage III: interdental bone loss extending to the middle third of the root, probing depths ≥6 mm, furcation involvement on 46, and mobility with a history of drifting. Stage IV would require masticatory dysfunction, bite collapse or fewer than 20 remaining teeth - none recorded here.
- Grade is about rate and risk. Bone loss of 40% at age 46 is more than the age-related expectation, and two grade modifiers push toward C:
- Smoking ≥10 cigarettes/day - she smokes 20, which is a recognised grade modifier.
- Diabetes with HbA1c ≥7.0% - her HbA1c of 8.8% is a recognised grade modifier, even though diabetes is not itself an independent grade determinant.
- The classification matters practically: it predicts that she will progress despite adequate treatment unless the modifiers are addressed, which changes the emphasis of the consent conversation and the review interval.
Additional implication: her attendance limit of one appointment every six months is incompatible with active periodontal therapy as usually delivered. That is a planning problem to be solved openly, not silently accepted.
2. Set out a treatment plan that is realistic given her stated constraints, and justify the sequencing.
Read the worked answer
Phase 1 - risk factor modification and initial therapy (the priority)
- Smoking cessation: brief advice, referral to Quitline or her GP for pharmacotherapy. This is the single most powerful modifier available.
- Written liaison with her GP about the HbA1c of 8.8% and the bidirectional relationship with periodontitis: successful periodontal therapy can modestly improve glycaemic control, and poor control impairs healing.
- OHI and tailored interdental aids; explain that shift work and fatigue are barriers to plan around, not to lecture about.
- Compress the delivery: rather than four quadrants, consider two longer appointments (or one extended session) of full-mouth scaling with local anaesthesia, accepting that this trades efficiency against patient tolerance. Do not offer subgingival instrumentation without local anaesthesia at 7 mm depths.
- Consider adjunctive systemic amoxicillin 500 mg plus metronidazole 400 mg three times daily for 7 days, but only as an adjunct to instrumentation in Stage III generalised disease - never as a substitute, and counsel about adherence and interactions.
Re-evaluate at 8-12 weeks with a full periodontal chart. Do not promise outcomes before this point.
Phase 2 - definitive care
- Tooth 46: hopeless. Discuss extraction. It is symptomless, so it is not urgent; the timing question is whether to extract before or after glycaemic improvement. With HbA1c 8.8% healing is slower and infection risk is higher, but a periodontally hopeless tooth is a chronic bacterial reservoir. Reasonable practice: extract after initial therapy, with consent about delayed healing, and avoid an unscheduled emergency.
- Restorative/orthodontic assessment for the drifted incisors only after periodontal stability.
Phase 3 - supportive care every 3 months, not 6, given Grade C, then extend if stable. Explain why the interval is non-negotiable - this is a maintenance disease, and 6-monthly review with 7 mm pockets will not hold.
3. She asks whether the bleeding is 'just from the diabetes' and whether antibiotics alone would fix it. How do you answer?
Read the worked answer
No on both counts, and the reasoning matters more than the answer.
- The bleeding reflects active inflammation from a dysbiotic subgingival biofilm. Diabetes and smoking are effect modifiers, not causes. They worsen the inflammatory response and impair repair, which is why her disease is more severe than her plaque levels alone would predict. Attributing it to diabetes alone removes her lever of control and is inaccurate.
- Antibiotics without debridement do not work. Systemic antibiotics reach the subgingival flora poorly in the presence of mature calculus and biofilm; they produce temporary suppression and then recurrence, while exposing her to resistance risk, interactions with metformin and possible candidiasis. They are indicated only as an adjunct to thorough instrumentation in selected cases.
- Importantly, periodontal treatment itself is part of her diabetes care. Good evidence shows that effective periodontal therapy is associated with a modest reduction in HbA1c. This reframes treatment as helping her GP's goal, which is a useful motivator.
- Be honest about prognosis: if she continues to smoke 20 a day and her HbA1c stays above 8%, treatment will produce less than it otherwise would. That is not a reason to withhold treatment, but it must be part of informed consent so that she does not experience an unexplained failure and lose trust.
- Document the discussion and the offer of cessation support.